Durable Response: 5 Years After Adjuvant Combo in Melanoma Durable Response: 5 Years After Adjuvant Combo in Melanoma

Double targeted therapy conferred durable long-term relapse-free survival when given in the adjuvant setting in advanced melanoma.Medscape Medical News
Source: Medscape Hematology-Oncology Headlines - Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news